Navigating the maze of cancer: How precision medicine unravels the unknown

by Simon L. April-Monn , Medical XpressPrecision medicine at the forefront. Guided by precision medicine, we pioneer tailored therapies for rare GEP-NENs, leveraging innovative tools to adapt treatmen

Updated on: March 30,2024

Navigating the maze of cancer: How precision medicine unravels the unknown

by Simon L. April-Monn , Medical XpressPrecision medicine at the forefront. Guided by precision medicine, we pioneer tailored therapies for rare GEP-NENs, leveraging innovative tools to adapt treatmen

Updated on:March 30,2024

In fight against prostate cancer, caring for mental health is a growing priority

by Anthony King,Horizon: The EU Research & Innovation MagazineCredit: AI-generated imageProstate cancer is the second most common cancer in men and its diagnosis—and treatment—can take a tol

Updated on: February 03,2024

In fight against prostate cancer, caring for mental health is a growing priority

by Anthony King,Horizon: The EU Research & Innovation MagazineCredit: AI-generated imageProstate cancer is the second most common cancer in men and its diagnosis—and treatment—can take a tol

Updated on:February 03,2024

Researchers identify new therapeutic approach to preventing cancer from spreading to the brain

byMcMaster UniversityCredit: CC0 Public DomainIn a studypublishedin the journalCell Reports Medicine, researchers Sheila Singh and Jakob Magolan discovered a critical vulnerabi

Updated on: October 21,2024

Researchers identify new therapeutic approach to preventing cancer from spreading to the brain

byMcMaster UniversityCredit: CC0 Public DomainIn a studypublishedin the journalCell Reports Medicine, researchers Sheila Singh and Jakob Magolan discovered a critical vulnerabi

Updated on:October 21,2024

Researchers identify drug resistance factors for advanced prostate cancer

by Mayo ClinicThe DNA/RNA processing used both single sample and multi-sample analyses as part of the processing. Credit:Molecular Cancer Research(2022). DOI: 10.1158/1541-7786.MCR-22

Updated on: February 20,2024

Researchers identify drug resistance factors for advanced prostate cancer

by Mayo ClinicThe DNA/RNA processing used both single sample and multi-sample analyses as part of the processing. Credit:Molecular Cancer Research(2022). DOI: 10.1158/1541-7786.MCR-22

Updated on:February 20,2024

New study targets major risk factor for gastric cancer

by University of Miami Leonard M. Miller School of MedicineCredit: CC0 Public DomainWhat if we could eliminate a major risk factor for stomach cancer in Black, Asian, Latino and other vulnerable

Updated on: April 06,2024

New study targets major risk factor for gastric cancer

by University of Miami Leonard M. Miller School of MedicineCredit: CC0 Public DomainWhat if we could eliminate a major risk factor for stomach cancer in Black, Asian, Latino and other vulnerable

Updated on:April 06,2024

Protein discovery sparks treatment hope for aggressive cancer

by Walter and Eliza Hall Institute of Medical ResearchTreating acute lymphoblastic leukaemia cells with the drug CX-5461 disrupts the nucleolar ribosome machinery shown by the fibrillarin protein

Updated on: March 20,2024

Protein discovery sparks treatment hope for aggressive cancer

by Walter and Eliza Hall Institute of Medical ResearchTreating acute lymphoblastic leukaemia cells with the drug CX-5461 disrupts the nucleolar ribosome machinery shown by the fibrillarin protein

Updated on:March 20,2024

An under-the-radar immune cell shows potential in fight against cancer

by University of British ColumbiaCredit: CC0 Public DomainOne of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreadin

Updated on: May 20,2024

An under-the-radar immune cell shows potential in fight against cancer

by University of British ColumbiaCredit: CC0 Public DomainOne of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreadin

Updated on:May 20,2024

Atezolizumab + bevacizumab shows benefit in met renal CA

(HealthDay)—For patients with metastatic renal cell carcinoma (mRCC), atezolizumab plus bevacizumab is associated with a progression-free survival benefit versus sunitinib, according to a study presen

Updated on: March 30,2024

Atezolizumab + bevacizumab shows benefit in met renal CA

(HealthDay)—For patients with metastatic renal cell carcinoma (mRCC), atezolizumab plus bevacizumab is associated with a progression-free survival benefit versus sunitinib, according to a study presen

Updated on:March 30,2024

Metabolic reprogramming of branched-chain amino acid facilitates drug resistance in lung cancer

by Chinese Academy of SciencesCredit: CC0 Public DomainDespite the remarkable success of molecular targeted therapy in recent years, the rapid increase of drug resistance is a major obstacle to e

Updated on: April 14,2024

Metabolic reprogramming of branched-chain amino acid facilitates drug resistance in lung cancer

by Chinese Academy of SciencesCredit: CC0 Public DomainDespite the remarkable success of molecular targeted therapy in recent years, the rapid increase of drug resistance is a major obstacle to e

Updated on:April 14,2024

Researchers develop affordable, rapid blood test for brain cancer

by Brandi Wampler,University of Notre DameThe biochip is used to detect biomarkers for glioblastoma, a fast-growing brain cancer. Credit: Matt Cashore / University of Notre DameResearchers at th

Updated on: September 07,2024

Researchers develop affordable, rapid blood test for brain cancer

by Brandi Wampler,University of Notre DameThe biochip is used to detect biomarkers for glioblastoma, a fast-growing brain cancer. Credit: Matt Cashore / University of Notre DameResearchers at th

Updated on:September 07,2024

Team develops test to predict immunotherapy response in kidney cancer

by UT Southwestern Medical CenterLeft, illuminated tumor by iPET expressing immunotherapy target, compared to control tumor (right). Credit: UTSWA novel imaging test shows promise for identifying

Updated on: May 27,2024

Team develops test to predict immunotherapy response in kidney cancer

by UT Southwestern Medical CenterLeft, illuminated tumor by iPET expressing immunotherapy target, compared to control tumor (right). Credit: UTSWA novel imaging test shows promise for identifying

Updated on:May 27,2024

Researchers identify a process responsible for therapeutic resistance in breast cancer

by McGill UniversityMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainResearchers at the Lady Davis Institute have identified a key protein that is

Updated on: March 01,2024

Researchers identify a process responsible for therapeutic resistance in breast cancer

by McGill UniversityMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainResearchers at the Lady Davis Institute have identified a key protein that is

Updated on:March 01,2024